For more guidance on planning your fat loss cycle, check our peptide cycle planning guide
This makes it particularly useful for individuals struggling with stubborn fat loss, even in cases where traditional weight-loss interventions fail
Peer-reviewed research has investigated AOD-9604 across animal models, ex vivo adipose tissue assays, and human clinical trials , with published studies appearing in journals including Endocrinology , the American Journal of Physiology Endocrinology and Metabolism , and Hormone Research
WADA clarified the prohibited status of AOD-9604 in 2013 following its mention in the Australian Football League supplements investigation, and the substance has remained named on the list in every subsequent annual revision
AOD-9604 acts on adipocyte lipolysis pathways through beta-3 adrenergic receptor signalling, with effects measured at the fat cell level
AOD9604 From R1250 Quick links Protocols 1